Journal of the American Association of Nurse Practitioners

Cover image for Vol. 29 Issue 8

Edited By: Charon Pierson

Impact Factor: 1.272

ISI Journal Citation Reports © Ranking: 2015: 38/114 (Nursing (Social Science)); 42/116 (Nursing (Science)); 67/88 (Health Care Sciences & Services)

Online ISSN: 2327-6924

Author Guidelines

Section 1: Overview and General Information
1.1 - Aims and Scope
1.2 – Correspondence
1.3 – Review and Response

Section 2: Manuscript Submission Criteria
2.1 - Publication Ethics
2.2 - Manuscript Files and Format
2.3 - Categories of Articles
2.4 - Size / Length / Fonts
2.5 - Style and References
2.6 - Footnotes

Section 3: Additional Guidelines
3.1 - Title Page
3.2 - Cover Letter
3.3 - Abstract
3.4 - Acknowledgements
3.5 - Electronic File Formats
3.6 - Tables, Figures and Graphics
3.7 - Permissions
3.8 - Copyright Transfer Agreement (CTA)

Section 4: Guidelines for the online submission process
4.1 - Prior to LOGIN
4.2 - Be Prepared
4.3 - After You Have Logged In
4.4 - Keyword Tips
4.5 - Manuscript File Naming for Submission
4.6 - After Your Submission is Complete

Section 5: Manuscript Submission Checklist

Section 1: Overview and General Information

1.1 - Aims and Scope

The Journal of the American Association of Nurse Practitioners (JAANP) is a monthly scholarly, peer-reviewed journal for Advanced Practice Registered Nurses (APRNs) and is the official journal for all members of the American Association of Nurse Practitioners (AANP; see for more information). Formed in 1985, the AANP is the largest and only full-service professional membership organization in the United States for NPs of all specialties. The JAANP supports the mission of AANP to lead NPs in transforming patient-centered health care with a vision of high quality health care for all by the patient’s provider of choice.

The mission of the JAANP is to help serve the information needs of nurse practitioners (NPs) and others with an interest in advanced practice nursing and patient-centered health care. Our collective vision is high quality health care for all by the patient’s provider of choice. The readers of the JAANP are mostly primary care NPs and other advanced practice registered nurses (APRNs), who provide care in domestic and international settings where they serve clients of all ages, manage a broad spectrum of acute and chronic conditions, prescribe a variety of medications and treatments, and function to the full scope of advanced practice nursing in their respective states and countries. Our organizational core values promote integrity, excellence, professionalism, leadership, and service, which is reflected in the way our members have embraced advanced education, lifelong learning, and the continued evolution of advanced practice nursing.

The JAANP encourages submission of scholarly articles addressing a broad range of topics appropriate to advanced practice nursing in the United States and internationally. Of particular interest in the current evolving health care delivery system are quantitative, qualitative, and mixed methods research studies answering new and novel problems; outcomes research addressing in particular outcomes directly affected by APRNs/NPs; cost-effectiveness or economic analysis of health care interventions used by APRNs/NPs; systematic reviews and meta-analyses of scientific literature of the benefits and harms of health care interventions; education research particularly related to NPs in DNP programs; health policy analysis related to advanced practice nursing in state, national, or international environments; practice improvement or quality improvement projects; and other new and evolving advanced practice nursing issues. International submissions that address new or novel advanced practice nursing issues throughout the world are also encouraged. Manuscripts must be original, unpublished works submitted for the exclusive use of the JAANP in accordance with our current author guidelines.

1.2 - Correspondence

All editorial queries and commentary should be sent by email to:

It is not necessary to send a pre-submission query. We recommend instead that authors visit the online journal website ( and check the table of contents and abstracts for the previous 12-24 issues to view the scope of topics covered in JAANP.

1.3 – Review and Response

All reviews are completed on-line via the ScholarOne ManuscriptsTM program and the results of reviews are sent to the authors at the email address entered into the system by the submitting author. We try to provide a first response within 60 days, however, this depends on the timeliness of the reviewers’ responses. Careful consideration is given to all submissions and decisions are rarely changed. If the author believes that misconduct on the part of the reviewers may have occurred (a conflict of interest for example), the author should contact the editor-in-chief and request a review of the decision. A decision of Reject is not sufficient reason to request a review, nor is the fact that the reviewers did not understand what the author meant to say. Poorly written or plagiarized material, flawed research, or a focus that is not appropriate for the journal’s audience are valid reasons for rejection.

We follow the guidelines from the Committee on Publication Ethics (COPE; in addressing author’s concerns about ethical processes. If the author believes that misconduct on the part of the editors is a concern, the appropriate person to contact is the nursing journals division of the publisher (John Wiley & Sons).

Section 2: Manuscript Submission Criteria

Manuscripts must be submitted via the ScholarOne Manuscripts™ JAANP online submission site at The steps must be followed exactly to assure your submission is complete. If all authors on the manuscript do not receive an automated e-mail response confirming the submission, the manuscript has not been successfully entered into the system.

2.1 - Publication Ethics

Authorship: The JAANP adheres to the principles stated in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. ( All authors should meet the criteria for authorship as stated in the ICMJE Uniform Requirements. The required Cover Letter must include a declaration all authors have contributed to the manuscript, a statement that the submitted manuscript has been read and approved by all the listed authors, and that the work is original and not under consideration by any other journal. All authors must also make a declaration of competing interests either in the cover letter or by completing the ICMJE Conflict of Interest Disclosure Form (available at and attaching that to the submission. A separate statement regarding conflicts of interest within the manuscript may also be required at the editor’s discretion and is covered in great detail in the section titled Acknowledgements (3.4).

All authors should have made substantial contribution to the manuscript submitted and be prepared to defend any content included therein. A statement about the role of each author must be included in the Title Page. To fully understand the issues of Authorship and Conflicts of Interest, authors are encouraged to read the full text of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at ( If changes are made to authorship following a revised submission, all authors must agree to the change by completing the Change of Authorship Form, available from the editor on request. Please include a statement of formal acknowledgment of those who do not qualify as authors based on the ICMJE authorship criteria.

Industry-sponsored manuscripts: The JAANP is a member of the Committee on Publication Ethics (COPE) and adheres to ethical publication practices. The JAANP adheres to the Good Publication Practices Guidelines, version 3, available online at for all sponsored material. Sponsorship must be clearly stated and all authors must complete the ICMJE Conflict of Interest Form.

Plagiarism: All manuscripts are submitted to iThenticate, a plagiarism detection program, prior to peer review. Manuscripts that appear to contain plagiarized material or to be duplicate submissions will not be reviewed and all authors will be notified of the iThenticate report. Significant issues of apparent ethical misconduct will be addressed according to the COPE guidelines (available at, which may include notification of Deans, supervisors, and/or institutional oversight or funding agencies of ethical breaches. Submitted manuscripts are treated as confidential material; however, the editor will share information on submissions for the purposes of investigating potential misconduct. Any sharing of confidential information will proceed according to COPE guidelines.

2.2 - Manuscript Files and Format

This section provides general guidelines for format and length of manuscripts and some specific guidelines for selected types of manuscripts. It is important that the submitter review the submission to assure that files are uploaded properly and that any author identifying information is removed from the main document files to assure a fair and blinded review process.

Manuscript text should not include page numbers, running heads, headers/footers, or hard returns at the end of each sentence (use the word wrapping feature of the word processor). Tables and figures should not be included in the body of the Main Document file. They should be in separate Table and Figure files and labeled appropriately (e.g., Table 1). More specific information about tables, figures, and graphics can be found in section 3.6.

Prior to submission you will need to do a word count (available on the MS Word Tools menu) of the Main Document file, excluding the abstract and references. This word count is to be entered in a specified data field of ScholarOne ManuscriptsTM during the submission process.

2.3 - Categories of Articles

We support the use of appropriate guidelines for reporting health research. Where appropriate in the following guidelines, we have mentioned specific guidelines to follow. Please consult the EQUATOR Network ( for more specific information. Follow the most current version of the guidelines you are using to prepare your manuscript.

Research: Several types of research manuscripts may be appropriate for JAANP; however, the focus of the research must clearly relate to NP practice. A clearly stated question or purpose must be provided early in the manuscript. Study protocols will not be considered for publication and pilot studies are rarely of interest because of the small number of subjects involved. Research generated from a larger parent study must be clearly specified and copies of ALL previously published papers from that study must be submitted as either an email attachment to the editor or uploaded into the manuscript system as a supplementary file for review. The primary outcomes study must be clearly identified and referenced in the background, literature review, or methods section of your manuscript.

All research reports must contain a statement in the methods section about the protection of human subjects and approval by the appropriate institutional review board (IRB). Research conducted on Federal property must also be approved by the appropriate Federal oversight review committee. Research conducted on Native American lands must be approved by the appropriate oversight review committee, which may be a tribal Council or specialty IRB. Checking the appropriate box on the Manuscript Details form in the submission process is also required.

Research references should primary sources and be the most current references available. Classic articles related to methods or instruments are acceptable. Additional references may be included in a table for on-line supporting information.

Observational Studies (cohort, case-control, cross-sectional): Please follow the STROBE guidelines to assure all elements are reported appropriately. ( Some of the extension guidelines at this link may be appropriate for reporting outcomes research.

Parallel Group Randomized Trials: Please follow the CONSORT guidelines to report experimental research and include the trial registration number. ( Note that there are supporting files for extensions of the CONSORT guidelines to address specific issues in other types of experimental design, such as trials assessing non-pharmacologic treatments, which may be more appropriate to reporting your study.

Qualitative Research: For qualitative research, the type of analysis and control for rigor and credibility must be clearly stated. Any identifying information in responses from subjects must be removed. Two guidelines are likely to be most useful for JAANP authors: ENTREQ and COREQ. (

Quality Improvement Research: Quality improvement research must be clearly differentiated from experimental design. The appropriate guideline for reporting a QI research project is the SQUIRE guidelines ( Note that any research design used in the project must be carefully reported using appropriate guidelines for research reporting as described in the EQUATOR Network (

Statistical Reporting Guidelines: A useful guide for reporting statistical analysis and methods in research can also be found on the EQUATOR Network. The SAMPL Guidelines cover most types of statistics and methods used in quantitative research. (

Reviews: We consider only systematic reviews either with or without meta-analysis. A systematic approach to finding relevant studies, for example the PRISMA Statement (, the Joanna Briggs Institute ( or the Cochrane Collaboration (, should be used as a guideline for reporting reviews. Authors should clearly describe the system they used to assure they have produced an unbiased review, including search strategies, inclusion/exclusion criteria, and evaluation of the strength of the reported research. Lengthy tables reporting study findings should be included as online supporting information.

Sponsored Reviews, developed by authors in collaboration with medical communications companies or independent medical writers and funded by pharmaceutical or device companies, cannot be considered at this time unless the sponsoring company is willing to pay for the supplementary pages required to publish the article. If sponsorship includes paying for supplementary pages to the journal, sponsored articles will be considered as long as they are unbiased and focus on entire drug/device classes or diseases, not just a single product. Off-label use of drugs in any drug review must be clearly identified. Conflict of Interest declarations must be completed by anyone submitting reviews of drug or devices. Sponsored material will be peer reviewed and must be relevant to NP practice. Contact Joann Mitchell ( for further information on sponsored material. We adhere to the principles stated in Good Publication Practices Guidelines, version 3, available online at

Brief Reports. Manuscripts with limited focus will only be considered for Brief Report formats. These manuscripts are no longer than 3000 words and limited to 30 references. Topics must be unique and of broad interest to NPs.

Health Policy. Health policy is broadly defined by the World Health Organization as “decisions, plans, and actions that are undertaken to achieve specific health care goals within a society.” Analysis of health policy issues related to NP practice are of interest to readers of JAANP. Topics must present new ideas and have broad implications for NP practice in national or international arenas.

Clinical and Case Study articles. Generally, this category is not a high priority for JAANP and will only be considered if the content is unique, cutting edge, or pertains to a special topic or themed issue. It is a good idea to query the editor directly at to ask if the topic is of interest and to explain your expertise as the author of the potential article.

Supplements: Supplements must have sponsorship and all proposals for supplements are first reviewed by the Wiley Development Team ( and referred to the Editor. All material submitted for supplements must follow all these guidelines and go through the peer-review process. The JAANP adheres to the Good Publication Practices Guidelines, version 3, available online at

Special Articles: Occasionally, the editorial board will solicit articles from experts in a specific filed to address a narrow topic of interest to the profession. These articles will be titled Special Articles or they may appear as part of an ongoing series such as the Scholars Corner.

2.4 - Size / Length / Fonts

The title should be no longer than 25 words and should reflect the content of the paper.

The body text of a typical manuscript, excluding abstract, references, tables, figures or graphics, should not exceed 4,000 words. Longer articles may be considered at the editor’s discretion. Text should be double-spaced, with approximately one inch margins.

Standard Fonts such as “Times New Roman” or “Times” are preferred. For maximum clarity, use sans serif fonts “Arial” or “Helvetica” for labeling figures, and “Symbol font” for Greek letters and the MS Word symbol menu for other unusual characters. Unusual fonts may not be supported on all systems and may be lost on conversion of your documents at the time of online submission.

If you have used the Track Changes feature in the process of writing and editing your manuscript, please save a final version that accepts all the changes you intend to include before you upload your file.

2.5 - Style and References

The Publication Manual of the American Psychological Association 6th edition (APA) is the style manual used by the JAANP to format citations, references, headings, and other matters. The use of electronic bibliographic citation managers (such as EndNote™) is both acceptable and desired. There are special provisions for submission within the ScholarOne Manuscripts™ system that may make submission easier for those who use EndNote™.

DOI numbers in citations are the preferred method for all citations and in particular, for “on-line ahead of print” or “early-view” manuscripts. References for manuscripts in-press are acceptable but they must be updated before the manuscript is published. There is extensive information about the use of DOIs in the APA 6th edition if you have questions.

References are limited to 50 for most articles except Brief Reports which are limited to 30 and systematic reviews which may exceed 50. Pay particular attention to the APA requirements for citation of on-line material. This has changed significantly in the latest edition.

References should be listed alphabetically in a separate section at the end of the body of the manuscript Main Document file, double-spaced under a heading titled References. Do not put them in a separate file. References should be current and journal titles should not be abbreviated. For most manuscripts, citations older than five years, other than classic works, are rarely required. It is the author’s responsibility to assure that all references are complete and accurate. Manuscripts that do not conform to referencing guidelines will not be reviewed. Retracted literature should not be cited other than in the context of the retraction.

Reference works not cited in the main text should be deleted from the manuscript. In some cases it may be useful to create a table titled Useful Resources or Useful Websites for inclusion as on-line supporting information. There is also helpful information about references for systematic reviews included in the latest edition of the APA.

2.6 - Footnotes

Do not use footnotes in the abstract or the main body of the manuscript; parenthetical comments are preferred over footnotes but should be used sparingly. Footnotes to tables or figures should clearly spell out all abbreviations used. Statistical significance may also be indicated with footnotes.

Section 3: Additional Guidelines

The following section details specific elements of the submission that are required at the time of submission.

3.1 - Title Page

The information on Title Page contains more than just the title and will be used at production time to properly identify the authorship of the manuscript. The title of 25 words or less (50 characters including punctuation and spacing) should be descriptive, unambiguous, and entice the audience to read your work.

Following the title should be a list of all authors in the order in which they will appear in published form, along with institutional roles and affiliations. The contact author must be clearly identified (this does not have to be the first author) along with complete contact information. Alternative email addresses and phone numbers are helpful in case we encounter difficulty contacting you.

The role each author filled in the development of the manuscript must be identified in a separate statement in the Title Page. For example, Mary Jones developed the instrument and performed all the analyses; Susan Smith wrote the initial draft of the manuscript; both authors developed the research project, collected chart data, and revised the manuscript for final submission. See the ICMJE Authorship Criteria if you have difficulty deciding what roles must be included in an authorship statement.

Any disclaimers required by Federal law (e.g., military, Federal Government) should be included on the title page.

3.2 - Cover Letter

The cover letter must contain the title of the manuscript, a statement about authorship as described previously (see section 2.1 Publication Ethics), and attestation that the manuscript is submitted in accordance with the current author guidelines (see version date at the bottom of this page) for the sole consideration of the JAANP and the material has not been published in any form previously. If the material has been presented at a conference or is part of a larger study (e.g., a subgroup analysis), that should also be stated. Please attach copies of all previously published articles from the study. If articles have been submitted elsewhere but not published yet, please summarize the differences between the manuscripts in the cover letter.

If the paper reports findings from a clinical trial that has been registered, include the registration information. If the paper requires special consideration related to the NIH Public Access Mandate, please alert us with a statement in the cover letter.

3.3 - Abstract

The JAANP Abstract follows a structured style. It must be formatted with the following four specific headings -- each separated by a blank line: Background and Purpose; Methods; Conclusions; and Implications for Practice. Do not use citations in the abstract. The abstract (the first item in the main document) must be copied into a designated abstract field during the submission process. Reviewers receive the abstract from this field when they are asked to perform a review – so it is the first impression you make on a reviewer. . NOTE: There is a firm 200 word limit for the abstract in the abstract field.

3.4 - Acknowledgements

Acknowledgements fall into two categories - Personal and Expository.

Personal acknowledgements are used to acknowledge such things as competitive grant funding and unpaid editorial assistance from mentors and colleagues. To avoid compromising the author’s anonymity, these acknowledgements are to be uploaded in a separate file during submission designated as a “Supplementary file not for review”.

Expository acknowledgements are used to divulge those items pertaining to conflicts of interest (COI) and funding for the development or editing of any article that mentions specific drugs, devices, or other proprietary content. This includes any editorial or writing assistance provided by pharmaceutical, manufacturing, or medical communications companies, which must be clearly acknowledged including the name of the editor/writer and the source of funding. Author employment by or affiliation with any company mentioned in the manuscript must be disclosed. These acknowledgements are to be uploaded in a separate file during submission and designated as a “Supplementary file for review.” Details of this support must also be copied into the corresponding fields of the online Manuscript Details form. This file will be included in the information accessible by reviewers, so it's important to use author initials or author 1, 2, etc, when disclosing any funding to maintain anonymity.

NOTE: If the submitter checks “no” to the “Do you have any conflict of interest?” statement, you are declaring that: No relationship exists between any of the authors and any commercial entity or product mentioned in this article that might represent a conflict of interest. There was no solicitation of the author(s) by any commercial entity to submit the manuscript for publication.

If you have no COI to declare, checking the box on the Manuscript Details page in your submission is sufficient. If a failure to disclose a relevant COI is discovered after final publication of the manuscript, the editor may decide to retract the article, or at least publish a correction or statement of concern.

To review the scope of COI go to the link at ICMJE ( that explains in detail what are considered relevant COIs. Whenever there is a possibility of a COI regarding commercial interests and the content of a manuscript, all authors are required to complete the ICMJE COI Disclosure form disclosing this potential or actual conflict-of-interest. This form is available in the public domain for authors to complete and upload with their submission at

3.5 - Electronic File Formats

The Main Document file of the submission must be in a .DOC, .DOCX (not DOCM or .WKS), .RTF or other Microsoft Office compatible file format. Further information on file formats can be found under the Get Help Now tab of ScholarOne Manuscripts™ manuscript central website. Main document files are not acceptable in .PDF.

3.6 - Tables, Figures and Graphics

Tables, Figures, and Graphics must not simply duplicate what has been said in the body of the manuscript. If they do not enhance the text, they may be eliminated for space considerations. Tables, figures, and graphics must be cited in the text in the appropriate location (e.g., see Table 1). Footnotes to tables or figures should clearly spell out all abbreviations used. Statistical significance may also be indicated with footnotes. Online-only supporting materials (such as data tables, maps, a review matrix, and interview forms) may be considered at the time of publication at the editor’s discretion.

Tables should be numbered with Arabic numbers in the order in which they are mentioned in the text. Each table should be double-spaced and include an appropriate caption. Every column must have a description or heading. Demographic tables must clearly indicate the total N either as a footnote or in a column heading. Use a table function to create your table – do not use tabs or the spacebar to create columns (this will result in columns that do not align properly when your submission is converted to HTML or PDF).

Tables must be in an editable file format such as .DOC or .DOCX (not PDF). Figures and graphics should use one of the file formats recommended by the publisher at:

All figures must have captions, which can be included as a separate file labeled “Figure Captions” if it is not possible to include the caption on the figure itself. Figures that are not high resolution may be deleted from a manuscript prior to publication, so it is helpful to provide the highest quality figure on submission or with revisions to assure a timely publication. Your manuscript will not proceed to the editor until artwork conforms to the guidelines.

Tables and figures should be uploaded as separate files during the submission process.

3.7 - Permissions

Authors must obtain any necessary permissions to reproduce previously copyrighted materials. Permissions to reprint Tables, Figures, Graphics, Instruments, or any other previously copyrighted information should accompany the manuscript at the time of submission. The copyright holder may be a publisher, an author, an agency, or any combination thereof. Be sure you have requested permission from the actual copyright holder, which is not always the author.

If a payment for permission to reprint is required, it will be the author’s responsibility to pay all fees prior to publication and submit evidence of such payment to the editor. NOTE: Do not pay fees until the manuscript has been accepted and scheduled for publication. Permissions should be scanned or copied into a file and uploaded as a “Supplementary file not for review.” Permissions must include both print and electronic publication. Permissions granted to students for materials included in a dissertation or project do not cover publication in commercial journals; therefore, a separate permit is required.

3.8 - Copyright Transfer Agreement (CTA)

The CTA is a legal document required by the publisher prior to publication. A link to the electronic CTA form will be provided by the production services and must be completed for publication to continue. The copyright is assigned to the AANP as the owner of the JAANP; however, the CTA further outlines your retained rights and permitted uses and allows for the posting of NIH grant-funded work to PubMed Central upon acceptance of the final manuscript. There are also special provisions for work produced by employees of the U.S. Federal Government (which includes all military services), as well as other government employees, so that your work will reside in the public domain. For those desiring to make their articles freely available by open access, please see

Section 4: Guidelines for the online submission process

The JAANP uses the ScholarOne Manuscripts™ (S1M) online submission processing system.

Submission site URL:

To make a submission you must login to your S1M JAANP account. If you do not have such an account you must create one. (NOTE: most S1M JAANP MC Accounts can be dual role Author/Reviewer accounts so if you are an active JAANP reviewer you should already have an account.) If you are creating a new account, that account will only be for Author status.

A submission by an author’s agent is acceptable. If you are a submitting agent for the manuscript (i.e., a project manager or administrative assistant), you should enter all the required submitter information under your own name and check the appropriate box so that you will not be listed as an author.


Before you log in to create/update your account and start a submission we suggest that you print out this file, read it, and then use it as a reference.

• Have an email address for all authors and have a permanent backup webmail address (e.g., hotmail, yahoo, Gmail) for yourself and any second author.
• Decide how you wish you and your co-author(s) to be addressed: Dr., Miss, Mr., Mrs., Ms, or Prof. (If your manuscript is accepted for publication you will be able to update your credentials, address, affiliation, etc. at proof reading time.)
• Make sure that there are no page numbers in your main document. (Nothing should be in the header or footer.)
• Determine the approximate number of words in your main document.
Select keywords for both your account and submission. (See Key word Tips below)
• Limit your Title to 30 words.
• Limit your Running Head to 50 characters (letters, punctuation, and spaces.
• Limit your Abstract to 200 words and ensure it is structured according to the JAANP Author Guidelines.
• Create a cover letter document that includes the required information described above. You may enter or copy and paste your cover letter text into a "Cover Letter" box OR you can attach a file containing your cover letter following the onscreen instructions.

NOTE: Submissions that do not comply with the GFA will incur delays or may be rejected immediately.

4.2 - Be Prepared To:

• Confirm that the manuscript has been submitted solely to this journal and is not published, in press, or submitted elsewhere.
• Confirm that all the research, citations, and authorship statements meet appropriate ethical guidelines, including adherence to the legal requirements of the study country. By confirming this statement you are declaring that you have read and understood the ethical guidelines published by the International Committee of Medical Journal Editors (ICMJE) available online at
• Confirm that you have prepared a complete text minus the title page, acknowledgments, and running head with no author names, to allow blinded review.
• State if you have any conflicts of interest.
• Enter your ORCID identifying number in the designated location. If you do not have an ORCID number, please read about it at The ORCID system allows you to maintain a complete record of all your published work regardless of any past or future changes to your names (e.g., M A Smith, Mary Smith, Mary Anderson Smith, Mary Anderson).


NOTE: If necessary, you may interrupt the submission process and logout. When you are ready to resume, just login, go to the author dashboard and click the "Continue submission" button.

In the "Degree" field please enter only your highest earned academic degrees. Note that MSN(c), PhD(c) and DNP(c) are not actually degrees and should not be used.


You will be required to select four keywords for the creation of your account and each submission. The JAANP keyword selection list found in S1M is fixed. It contains almost 800 broad-based nursing science keywords that should be suitable for most submissions. Your account keywords should reflect your areas of professional expertise and interest as well as the keywords specific to your manuscript. The keywords selected for your submission should reflect the content of your manuscript. Keywords should be found in the title and the abstract of your manuscript; careful crafting of your keywords is essential for discovery of your published article. You may provide a list of additional keywords in the TitlePage.doc if you do not find suitable ones in the S1M list but you will need to select 4 keywords from the list in order to proceed.

TIP: When selecting keywords from the list, enter three or four letters AND an asterisk (wild card symbol) to filter the list.

Upload your submission files in the upload-order specified below.

NOTE: The JAANP conducts a blinded peer-review. When uploading your manuscript you must upload a Main Document file with no author identifying information in it (designated as the Main Document) and a separate title page (designated as theTitle Page) with all author identifying details including an email address for all authors. This is the author information you would like the readers to see in a published article. The next section details file type and naming conventions.

4.5 - Manuscript File Naming for Submission

The S1M system will demand that you designate your files as one of the following types:

Title Page is required. It should include the title of the submission and complete author contact and work affiliation information. Authors should be listed in proper order as you want them listed for publication and the corresponding author must be clearly identified. See section 3.1 for more detail about the Title Page.

NOTE: The title page is not included in the reviewer files when the manuscript is sent out for review.

Main Document is required. It includes the body of the text and references with all author identifying information removed, no page numbers, no running head (which is entered in S1M in a separate data field), and no embedded tables or figures. If you have been using Track Changes to make final editorial corrections to your document, be sure to accept all changes and save the corrected file with Track Changes turned off. (Track changes leaves contributors’ names visible in the document unless this step is completed.)

Tables and Figures should be separated into individual files and uploaded with appropriate labels applied as requested during the submission process.

Supplementary Files Not for Review may be uploaded to provide specific information such as permission to reprint material, a completed and signed ICMJE conflict of interest disclosure if required, or a copy of the letter of approval to conduct research from the appropriate review board.

Suggested upload-file name conventions: (Contact Author Last name and _Initial followed by file type).

NOTE: The S1M system uses the following user selectable file designations Title Page, Main Document, Figure, Table, or Supplemental (may or may not be designated for review) This is the specified upload-order.

Smith_A TitlePage.doc
Smith_A MainDoc.doc
Smith_A Figure-1.tif
Smith_A Table-1.doc
Smith_A SupFile-Acknowledgments
Smith_A SupFile-Permit.doc

In all cases the Main Doucument file should have the Contact Author's name prepended to it. eg. Smith_A MainDoc.doc

During the upload process your files will be converted into both HTML and PDF format for use by the reviewers. Sometimes the conversion process takes a while or fails. If it seems to be taking too long, close the conversion-in-progress window and check to see if a file conversion actually occurred. If the file conversion appears stalled or failed, follow any instructions that appear on the screen. Otherwise delete any corrupted files and start the process over.

Please be aware that S1M services millions of users and sometimes you may experience a glitch in file conversion processing (e.g. "Unable to convert file Author_N1 CL.doc [PDF]" it did make an HTML) and you may have to delete a botched job and restart the process.

Once your submission is complete you will receive an automatic email from the S1M system verifying your submission and providing you with your Manuscript ID Number. You will be able to track the progress of your submission from your Author Center in the S1M system.

It is not possible for authors to change or add anything once the submission is complete. If you fail to follow the guidelines or you need to add or change something to your submission, we will have to “unsubmit” your manuscript for you to resubmit your corrected files. This can cause delay!

4.6 - After your submission is complete

All authors will receive an automated confirmatory email that the submission has been accomplished. Any further communication regarding the review, revisions, decisions, or production details are only sent to the contact author (or submitting agent). It is the contact author's (or agent's) responsibility to maintain communication with all other authors throughout the process. Failure to do so may result in production delays.

If you need to query the editors about your submission, please include the Manuscript ID number you received in the confirmatory email. This makes finding your submission easy and accurate.

All manuscripts are first reviewed by the editor-in-chief for appropriateness and suitability for the journal audience. If your submission is not appropriate, if there are problems with overlap with previously published material, or if the writing style and content are not a the level needed for our readers, the manuscript may be rejected by the editor without sending it to peer reviewers.

Thoughtful, high quality peer review takes time, so we ask for your patience with this process. We will give your manuscript every possible consideration but we do receive many more submissions than we can possibly publish so we have to reject a lot of submissions. Some of those rejected manuscripts may even be well written and appropriate for publication in other journals. When possible, the editor will try to suggest other venues for publication of your manuscript. In general, we receive the largest number of submissions just before summer and year-end holidays, so the review process can take longer during the summer months and between the US Thanksgiving and New Year’s holidays. Although our rejection rate varies depending on the number of submissions, it has consistently been around 75%.

Once your article is accepted you will be invited to register with Wiley Author Services at where you will be able to track the production status of your article. Take advantage of the opportunities to register your co-authors and other colleagues (up to 10 people) to receive notification and a free copy of your published article.

You can also help increase the reach and impact of your publication by registering with Kudos ( and using the toolkit provided to help you create greater awareness of your research. Kudos is free for researchers through a partnership with Wiley.

If you are on Twitter, you can also send a tweet about your publication to @JAANPEditor, @AANP_News, or @Wiley_Nursing about your article for broader dissemination.


JAANP This is a summary checklist of the essential elements for your submission. Please be sure that everything is included as directed in your submission to avoid administrative delays.

Title Page
(See Section 3.1)
Contains title of manuscript in 25 words or less, complete author list in correct order with contact and work information, contact author clearly identified with active email address, statement of contributions for each author
(See Section 3.3)
Formatted with required elements: Background and Purpose, Methods, Conclusions, Implications for Practice
Cover Letter
(See Section 3.2)
Contains the title, statement of authorship and exclusive submission to JAANP, any conflicts of interest relevant to the work, states the work conforms to Guidelines for Authors with current revision date
Main Document
(See Section 2)
All identifying author information removed, no page numbers or running head included, any drugs named as follows: generic (Trade - optional)
Tables, Figures, Graphics
(See Section 3.6)
Captions are complete, footnotes added where necessary, each table, figure or graphic is cited in the text in the appropriate location
(See Section 3.4)
Expository information does not identify authors by name, funding sources and writing/editing support is explicitly acknowledged by name
(See Section 3.7)
Required for previously copyrighted material and must be uploaded with the submission